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SERUM ALPHA-FETO·PROTEIN*
n. CORRELATIO OF SERUM LEVELS WITH OTHER BIOCHEMICAL PARAMETERS I r PRIMARY CA CERS
OF THE LlVER
L R. PURVE , M.B., B.CH., M.MED. (PATH.) and I. BERSOH , B.Se., M.B.. B.CH., F.e. PATH.. SOl/th African
Institl/te for Medical Research, Johannesburg
Quantitative immuno-a ay methods have been able to
detect alpha-feto-protein in the sera of about 78°0 of
cases of primary cancer of the liver down to the lowest
present practical limit of 0,' mg./ 100 m!.'
Previous studie have shown that there are no bio-
chemical' tests capable of completely distinguishing cases
of primary cancer of the liver from other causes of liver
dysfunction, especially when this takes the form of a
space-occupying le ion, although there are patterns of
results that are highly suggestive.'" A summary of the
biochemical tests· indicates which tests are similar and
dissimilar when the means of results in cases with pri-
mary cancer of the liver are compared with a hetero-
geneous group of non-cancer patients with similar clinical
pre entations.' Tests showing no ignificant difference
(p>O'OI) between the cancer and non-cancer groups are:
Thymol turbidity and flocculation, colloidal red, Takata-
Ara, zinc sulphate turbidity, bilirubin, cholinesterase,
mucoprotein, transaminases (SGOT and SGPT), sedi-
mentation rate, lactic dehydrogenase (LDH), isoenzymes
3 and 4 (0'0 of tota!), total serum protein, albumin (0'0 and
C/IOO m!.), alpha,-globulin (°0 and 0/ lOO m!.), gamma-
globulin (°0 and 0/ lOO m!.). haemoglobin, prothrombin
index, relation between alkaline phosphatase and bili-
rubin.
Tests showing significant differences between cancer
and non-cancer groups (p<O'Ol) are:
1. Higher in cancer group: Cephalin cholesterol, alka-
line phosphatase. cholesterol, aldolase, 5'-nucleotidase,
lactic dehydrogenase and all isoenzymes (in units), gluta-
thione reductase, i ocitric dehydrogenase, alpha,-globulin
(00 and 0/ lOO m!.), beta-globulin (% of total), leucine
aminopeptidase, hydroxybutyric dehydrogenase (SHBD),
ratio SOOT/SOPT, ratio LDH/SHBD.
2. Higher in non-cancer group: LDH isoenzymes I
and 2 (% of total), C-reactive protein, beta-globulin 0/
lOO m!.'
These cases were initially suspected clinically, before
biopsy, of having primary cancer of the liver, but the
diagnosis was ruled out by biopsy or by the absence of
serum alpha-feto-protein. Cases of viral and toxic hepa-
titis were excluded from this group on clinical grounds
and secondary hepatic tumours by biopsy or po tmortem
examination. The relative number of cases in the cancer
group (130) and in the non-cancer group (60) is a rough
indication of the reliability of clinical acumen alone.
When the percentages of cases appearing in the ab-
normal range of any test were compared, no test wa
found to have any real discriminating power between the
cancer cases and the heterogeneous non-cancer group."
This was not surprising, as most of the non-cancer cases
had enlarged livers due to a space-occupying process of
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tThere were 129 cases in the primary cancer of the liver group and 60 in
the nQn<ancer group (including case of bilharzia. tuberculosis, cirrhosi
of the liver and ch ronic congestive cardiac failure).
one type or another with related hepatitis.
It therefore appears that a clinical diagnosis receive
only slight support from a wide spectrum of liver func-
tion tests. The exceptions to this are, of course, hepatic
biopsy and the alpha-feto-protein test. In clinical practice
it should be possible to diagnose nearly 80°0 of case
with the alpha-feto-protein test alone, which in the serie
under discussion would have at least halved the number
of biopsies necessary to make a firm diagnosis.
An attempt was made to establish some correlation be-
tween serum alpha-feto-protein levels and the wide spec-
trum of biochemical parameters. In addition, difference
in the biochemical results were sought between alpha-
feto-protein positive and negative cases.
MATERIALS AND METHODS
We showed in a previous paper' that the range of serum
alpha-feto-protein results was very wide, ranging from
0·1 mg./IOO m!. to nearly 1,000 mg./ lOO m!. However,
the distribution on a logarithmic scale was uniform, and
so we have used the value of the logarithm (to the base
10) of the alpha-feto-protein result along the abscissa in
all our graphs.
An IBM 360 computer was used to store all the bio-
chemical data, to perform the statistical analyses and to
plot the graphs.
For this study, only the initial results were used, so that
the results reflect the undisturbed status of the patients
before antitumour or symptomatic treatment, except in
a few case.
In each case the logarithm of the alpha-feto-protein
result was plotted against the value of each of the tests
listed above. The resultant scattergram for each test was
used to gauge visually whether or not there was an ob-
vious element of positive or negative correlation.
RESULTS
Fig. 1 shows a selection of the scattergrams produced in
the case of alkaline phosphatase haemoglobin, % alpha.-
globulin, mucoprotein, lactic dehydrogenase and 'liver'
isoenzyme 5, zinc sulphate turbidity, % albumin and
cholinesterase activity.
There is a uniform lack of obvious significant correla-
tion of the alpha-feto-protein test with any other bio-
chemical parameter, and the scatter of results is fairly
uniform.
When the biochemistry of the cancer cases with a posi-
tive alpha-feto-protein result was compared with those
having a negative alpha-teto-protein there were no result
showing a highly significant (p<O'OI) degree of correla-
tion, but several showed a lesser degree (0'0 I<p<0·05).
viz. colloidal red, haemoglobin and total protein were
higher in the alpha-feto-protein positive group and muco-
protein, sedimentation rate, C-reactive protein and %



























should not correlate with any other. In addition, multi-
ple pathology was often pres::nt. e.g. bilharziasl or cir-
rhosis, which a!so tended to confuse the interpretation of
results.
1t should be stressed that not a single false positive
alpha-feto-protein result has yet occurred ID our series,'
which is approaching 200 cases, although we have not
yet had the opportunity of examining any case with non-
hepatic tumours having an embryonal element.'
There appears to be no ob ious correlation of tumour
size, rate of growth, degree of necrosis or the presence of
metastases with the serum alpha-feto-protein, but this i
still under scrutiny. There is a suggestion that the alpha-
feto-protein level is present less often in cases without
cirrhosis (approximately 50%) than those having cirrhosi
(approximately 85 00), but these results are being re-
evaluated and will be reported on in a subsequent article
in this series.
The enzyme tests are, as expected, higher on the
average In cancer cases than in the non-cancer group
since they reflect tumour growth and necrosis generally,'
and would therefore not be expected to correlate with
serum alpha-feto-protein levels.
since there is a dissociation of the
serum level of alpha-feto-protein
from tumour size, etc.
Initially it was thought that
alkaline phosphatase levels were
elevated out of proportion to
bilirubin levels in cases of primary
cancer of the liver. Detailed investi-
gation of this point revealed that
although cancer cases had elevated
alkaline phosphata e levels (80 U ,,)
more often than the non-cancer
group (46 00), discriminant analysis
was unable to separate the two
groups when the bilirubin result
was compared with the alkaline
phosphatase result. There was. in
addition, no correlation with the
presence or the level of alpha-feto-
protein .
It IS interesting that the alpha-
feto-protein negative group of
primary Liver cancer cases showed
elevations of tests which are usually
interpreted as being indicators of
tissue necrosis or 'activity' of a dis-
ease process (i.e. sedimentation
rate, mucoprotein, C-reactive pro-
tein, 0 0 alpha,-globulin). In addition
the total serum protein and haemo-
globin levels were lower. Taken to-
gether, these finding, all of border-
line significance (0,01 <p<0·05),
become more important. They may,
in fact, indicate a more 'active'
carcinogenic process in the alpha-
feto-protein negative group. On the
other hand, there are indications
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F,g 1. Lack of obvIOUS correlalton between alpha-fero·protein and other biochemical test. The
scauergrams were produced by inkmg in an JBM Calcomp plotter output The abSCissa ranges from
0.1 to 1,000 mg 1100 ml of alpha-feto-protein on a logarIthmic scale In every graph. The ordinates
all range from 0 to a value X which is different in each case.
A: Alkaline phosphatase (X = 100 KA units). B: Haemoglobin (X = 25 G/loo m!.). C:
% alpha i-globulin (X = 20%). D: Mucoprolein (X = 500 mg./loo mL). E: % lactic dehydro·
genase isoenzyme 5 (X = 40). F: Zinc sulphale turbidity (X.= 100). G: % albumin (X = 100%).
H: Cholinesterase (X = 100% of normal acltvlty). 1: Lactic dehydrogenase (X = 10.000 umts).
Point falling on the abscissa do not have a result for the corresponding biochemical test.
DISCUSSIO
When it IS considered that no single te t IS capable of
distinguishing cases of primary cancer of the liver with
certainty or even with a lesser degree of accuracy, it is
not surprising that a specific test like alpha-feto-protein
When the biochemistry of the cancer cases with alpha-
feto-protein results negative, below, and above 20 mg.f
lOO ml., were compared (this being approximately the
med:an for the range), some interesting tendencies were
observed (see Table I) again at borderline significance
levels (0'01 <p<0·05). In the 3 groups, a the alpha-feto-
protein changes from zero to less than 20 mg./IOO mJ.
and then to more than 20 mg./IOO ml., the following
tendencies were observed (means in brackets for the 3
groups: 0; <20; >20).
Mucoprotein decreases (211 - 180 - 167)
Cholesterol increases (152 - 164 - 198)
Erythrocyte sedimentation rate decreases (33 - 28 - 17)
Serum protein increases (7·81 - 8·11 - 8·25)
0t" alpha,-globulin decreases (108 - 102 - 93)
0t" gammaglobulin is constant (31-4 - 30·5 - 31·5)
Haemoglobin increases (12·7-13·7-15·0)
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TABLE J. CHEMISTRY OF CANCER CASES
Alpha-feto- Alpha-feto- Alpha-feto-
protein protein protein Student's T test
ormal negative <20 mg./IOO ml. >20 mg./IOO ml.
Test value (A) (B) (C) A/B B/C A/C A/B+C
Thymol turbidity (units) 2 4·2 (3 '0) 5 ·1 (7'6) 6·4 (3 '8) -0·62 -1·05 -2,55 -1,42
Thymol flocculation (units) leg. 3·0 (I . I) 2·8 (I . I) 3·2 (I . I) 0·33 -1,12 -0,36 -0'19
Colloidal red (units) ego 3·3 (I '0) 3·5 (0'9) 3·6 (0'8) -(,12 -0'49 -1,57 -1,67
Cephalin cholesterol (units) ego 3·2 (1'0) 3·7 (I. 3) 3·5 (0'9) -1,08 0·69 -0,77 -0,99
Takata-Ara (units) Neg. 2·3 (0'7) 2·1 (0'7) 2·1 (0'9) 1·23 -0,39 1·12 1·21
Zinc sulphate turbidity (units) <12·5 33·0 (14,8) 33·2 (16' 8) 34·9 (12'6) -0·06 -0,58 -0,58 -0,51
Alkaline phosphatase (KA units) <13·0 28·8 (12'6) 28·8 (18' 3) 27·1 (l4'() -0,01 0·55 0·52 0·47
Bilirubin (mg./IOO ml.) <1·2 3·5 (6'7) 2·2 (4'1) 3·5 (7' 7) 1·09 -1,14 -0·01 0·88
Cholinesterase (% of normal) >80 65·9 (85 '4) 53·4 (24' 5) 55·2 (22' 6) 0·99 -0·39 0·84 1·27
Mucoprotein (mg./lOO ml.) <125 211·2 (79 '9) 180·6 (61'2) 167·2 (62 '6) 1·84 1·12 2·58 2·29
Total cholesterol (mg./IOO ml.) <200 152·6 (61'6) 164·8 (96 '0) 198·9 (96'9) -0,58 -1·81 -2'16 -1,29
Glutamic oxaloacetic transaminase
(units) <35 142·4 (107'7) 136·3 (124'2) 221·2 (256'4) 0·21 -2,22 -1,49 -0'99
Glutamic pyruvic transaminase
(units) <35 78·0 (52' 5) 73·9 (115'4) 62·2 (44'2) 0·17 0·70 1·39 0·64
Aldolase (units) <25 76·0 (75' I) 57·4 (58' 2) 54·9 (29 '0) 1·18 0·28 1·74 1·02
Sedimentation rate (Wintrobe-
mm./hr) <15 33·5 (20'2) 28·3 (18'6) 17·3 (16' 2) 1·07 3 ·18 3·63 2·31
5' -nucleotidase (units) <11 32·2 (23 '4) 38·7 (58' 5) 36·8 (29'1) -0'53 0·21 -0,68 -0,51
LDH (units) <280 817-9 (426' 8) 830·1 (685 '0) 1155-0 (1237'2) -0,08 -1,68 -1,28 -0,91
%isoenzyme I (normal means) 18 10-2 (4'9) 11·7 (5-7) 10·8 (5'6) -1·13 0·89 -0,40 -0·62
% isoenzyme 2 (normal means) 38 24·6 (7'7) 26·8 (8 .1) 25·9 (9'1) -(,12 0·67 -0,59 -0,74
% isoenzyme 3 (normal means) 27 20·9 (6'0) 20·6 (5' 8) 21·3 (6'2) 0·21 -0·56 -0·23 -0,01
%isoenzyme 4 (normal means) II 14·8 (4'7) 12·3 (5 '0) 11·6 (6' I) 2·07 0·67 2·30 2·14
%isoenzyme 5 (normal means) 6 29'5 (13'5) 28·7 (14'4) 30-4 (12 '9) 0·23 -0-66 -0·30 -0,17
Glutathione reductase (units) <54 193·6 (112'4) 128·7 (78 '0) 148·0 (126'1) 2·96 -0·96 1·52 2·26
Isocitric dehydrogenase (units) <7 12·4 (6- 5) 15-6 (15 '4) 15·6 (10'7) -0,96 -0,0 -1,32 -1,31
Total protein (G/ 100 ml.) 5,7-8,8 7·81 (0' 82) 8 ·11 (0' 88) 8·25 (0' 79) -1,45 -0-87 -2'28 -1,84
%albumin (normal range) 57-68 39·5 (6'0) 41·3 (6' () 40·7 (6'2) -1,26 0·51 -0,82 -0'78
%alpha,-globulin (normal range) 2-5 5·6 (0'15) 5·4 (0'17) 6·0 (0'17) 0·54 -1·90 -1,03 -0,52
%alpha.-globulin (normal range) 5-11 10·8 (2'2) 10·2 (2'2) 9·3 (1' 8) 1·20 2·29 3 '19 2·27
% beta-globulin (normal range) 8-16 12·6 (2'6) 12·5 (2'3) 12·5 (2' I) 0-21 -0,01 0·20 0·31
%gammaglobulin (normal range) 12-21 31·4 (6'4) 30·5 (7'8) 31· 5 (6' 5) 0·53 -0,71 -0'04 0·02
Leucine aminopeptidase (units) <330 585·5 (420'5) 642-5 (531' 5) 598'7 (333' 5) -0,47 0'51 -0'15 -0,26
Hydroxybutyric dehydrogenase
(units) <180 545·6 (381'8) 510·5 (459'0) 680·8 (838' 3) 0·33 -1,31 -0,76 -0,36
Haemoglobin (G/lOO ml.) >15 12·7 (2'5) 13·7 (2'3) 15'0 (3' I) -1·00 -2·44 -3,11 -1,93
Prothrombin (% of normal) >85 75·4 (11 .5) 76·1 (10'1) 75·3 (13' 3) -0,28 0·38 0·05 0·02
umber of cases 26 57 54
Degrees of freedom 81 109 78 135
The statistic, 'Student's T', was calculated by standard methods with degree< of freedom (total cases - 2) and the probability (p) of two sets of data, e.g. (A) and
(B +Cl, being significantly different was looked up in standard tables. For (e.g. 60 degrees offreedom) if 'Student's T' > 2· 39 then p < 0·01 and if2· 39 > 'Students'
T' > 1·67 then 0·05> p > O·OJ.
The mean and one standard deviation (in brackets) are given in the 3 categories.
The methods for the tests are the same as previously described,!. except that the Beckman microzone electrophoresis technique is used now with corresponding
changes in normal values.'
group has fewer cases of cirrhosis than the alpha-feto-
protein positive group (50% vs. 85%): The presence of a
damaged liver might inhibit the production of abnormal
proteins, thus causing the non-cirrhotic (and thus the alpha-
feto-protein negative) group to have apparently higher
levels of these abnormal proteins indicating 'activity'. How-
ever, this view is not supported by the data, as the cirrhotic
and non-cirrhotic cases of primary liver cancer can be dis-
tinguished on the basis of results of the f1occulations, zinc
sulphate turbidity and gammaglobulin levels." These differ-
ences do not appear at all (except for colloidal red) when
the alpha-feto-protein negatives and positives are com-
pared.
In spite of no obvious correlations when the scatter-
grams (of alpha-feto-protein level against the individual
biochemical test) were studied, a cruder subdivision of
cases into 3 groups-zero, less than 20 mg. / lOOm!. and
greater than 20 mg./l00 ml.-did reveal some, perhaps
significant, tendencies. The mucoprotein, sedimentation
rate and % alpha,-globuIin decreased progressively as the
alpha-feto-protein level increased. There was little bio-
chemical evidence of cirrhosis as the alpha-feto-protein
level increased (et. zinc sulphate turbidity and % gamma-
globulin). The cholesterol levels increased steadily with
increasing alpha-feto-protein levels. The significance of
this is not yet understood but might be related to the
cholesterol content of the tumour.
The amount of alpha-feto-protein present usually does
not contribute much to the % alpha,-globulins, so that it
is felt that the levels are only related to the quantities of
the usual alpha,-globulins.
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SUMMARY
There appears to be a reciprocal relationship between the
serum alpha-feto-protein level and the indicators of 'activity' of
a disease process, viz. mucoprotein, C-reactive protein, ery-
throcyte sedimentation rate and ~o alpha,-globulin. On the
other hand, the cholesterol, haemoglobin and total serum pro-
tein levels rose progressively. These findings could possibly, but
not necessarily, be related to the suspected' lower incidence of
concomitant cirrhosis in the alpha-feto-protein negative group
of primary liver cancer cases.
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FUNCTIONAL LEVELS OF AMPUTATION OF FINGERS*
ISIDORE KAPLAN, ER.C.S., ER.C.S. tEDlN.), Plastic Surgeon, Johannesburg
Amputation of an entire linger or part of it, a commonly
performed operation, is often regarded as a minor surgi-
cal procedure and usually delegated to the most inex-
perienced to perform. However, the decision to salvage
or ablate may require considerable thought and judge-
ment, the level of amputation of the affected digit re-
quires understanding of the dynamic function of the hand,
and the technique may demand advanced surgical skill.
Not only may the patient lose a digit unnecessarily, but
incorrectly performed amputation may result in a galaxy
of complications, rendering the amputated finger
functionless and impairing the over-all function of the
hand.
It is of paramount importance to realize that the ana-
tomical level of amputation does not necessarily corre-
pond to the functional level. The surgeon proposing
amputation must appreciate the full function of the hand
as a working unit, and accept responsibility for maintaining
as much function as possible or improving function if
necessary.
SURGICAL PRINCIPLES OF AMPUTATIO I I ITIAL INJURY
In a digit which has sustained traumatic amputation, it is
the duty of the surgeon to salvage all viable tissues.
Dogmatism cannot be the rule, for each case must be
tailored to the individual ne~ds of the patient. The domi-
nance of the hand, the level of amputation, the occupa-
tion and age of the patient, and the particular digit which
has sustained the injury must all be considered. Never-
theless, well-established criteria do exist in the technique
of amputation.
Skin
At the time of injury. all viable skin is conserved, and all
available flaps-volar, dorsal or lateral-must be utilized
to cover the stump. Length may not be sacrificed merely
because there is insufficient skin. though a bulky stump
"Date received: 24 January 1969.
with excess skin coverage is preferable to a LUmp tensely
enclosed.
Tendon Ends
SULUring the tendon ends over the stump adds nothing
to the amputation stump. The profundus tendons of all
lingers are interrelated and hence such suturing may result
in checkreining of the other profundus tendons, with
diminished functional excursion. Tendon ends should be cut
short and allowed to retract.
Nerve Ends
eurovascular bundles should be carefully isolated. and
the nerve ends should be dissected from the accompanying
artery, resected and allowed to retract proximally. leaving
the end neuroma to be placed away from the stump scar.
Bone Ends
The bone ends should be trimmed and shaped to
achieve a smootWy-contoured, cosmetically acceptable tip.
Preservation of the phalangeal heads creates bulbous tip
which, apart from being cosmetically unattractive. are func-
tionally inefficient.
AMPUTATION OF I DIVID AL FI 'GERS
Index Finger
The index finger is the most important of all the fingers.
It participates not only in gra ping, but also in pinching
function, with accurate pad-to-pad opposition of the
thumb. It is considered to represent 20% of the function
of the hand, and maintenance of length is of great im-
portance. It is the only linger where the application of a
cross-linger or palmar flap may be justified to maintain
length. The critical level of amputation is the proximal
interphalangeal joint. At, or proximal to, this level pinch
function is lost, the thumb utilizing the middle linger a
its oppositional member.
Though the amputation tump at the proximal phalan-
geal level will still contribute to gross grasp. thi short
